Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 790,107 | 579,745 | 217,511 | 160,711 | 25,086 |
| Depreciation Amortization | 462,059 | 380,293 | 375,870 | 402,208 | 439,435 |
| Income taxes - deferred | -139,549 | -81,555 | -106,337 | -115,539 | -135,553 |
| Accounts receivable | -57,565 | -70,701 | -37,009 | -8,518 | -76,529 |
| Other Working Capital | 174,342 | -79,760 | -103,285 | 139,776 | 258,714 |
| Other Operating Activity | 333,051 | 290,732 | 494,518 | 310,865 | 216,833 |
| Operating Cash Flow | $1,562,445 | $1,018,754 | $841,268 | $889,503 | $727,986 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -275,954 | -267,437 | -124,096 | 89,754 | -361,013 |
| Net Acquisitions | -25,000 | -95,789 | -303,451 | N/A | N/A |
| Purchase Of Investment | -3,184,197 | -2,968,916 | -1,959,365 | -1,454,147 | -3,213,051 |
| Sale Of Investment | 2,941,060 | 3,253,779 | 1,787,139 | 1,782,134 | 3,200,386 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -8,750 |
| Other Investing Activity | 178,218 | -208,209 | 0 | 0 | -8,750 |
| Investing Cash Flow | $-365,873 | $-286,572 | $-599,773 | $417,741 | $-382,428 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -178,716 | -5,399 | -11,860 | -9,639 | 9,931 |
| Debt Issued | 986,980 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,512,474 | -6,563 | N/A | -746,416 | N/A |
| Common Stock Issued | 178,486 | 489,180 | 146,959 | 119,619 | 273,535 |
| Common Stock Repurchased | -738,938 | -2,991,184 | -320,268 | -322,590 | -734,427 |
| Other Financing Activity | 30,037 | 1,780,627 | 36,759 | 10,503 | 0 |
| Financing Cash Flow | $-1,234,625 | $-733,339 | $-148,410 | $-948,523 | $-450,961 |
| Exchange Rate Effect | 776 | -558 | 124 | N/A | N/A |
| Beginning Cash Position | 659,662 | 661,377 | 568,168 | 209,447 | 314,850 |
| End Cash Position | 622,385 | 659,662 | 661,377 | 568,168 | 209,447 |
| Net Cash Flow | $-37,277 | $-1,715 | $93,209 | $358,721 | $-105,403 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,562,445 | 1,018,754 | 841,268 | 889,503 | 727,986 |
| Capital Expenditure | -275,954 | -284,106 | -198,312 | -318,376 | -361,013 |
| Free Cash Flow | 1,286,491 | 734,648 | 642,956 | 571,127 | 366,973 |